WASHINGTON — President Trump announced on Tuesday that Pfizer has agreed to offer lower prices on its drugs to the Medicaid program and directly to patients, the first in what he said would be a series of deals intended to secure cheaper prescription medicines for the U.S.
Pfizer also agreed to launch new medicines at prices “at parity” with those in other countries, the company and administration officials said. In return, provided Pfizer continues to invest in U.S. manufacturing, the company will not have to pay certain tariffs on drugs imported into the U.S., Trump said.
